irinotecan accord
accord healthcare b.v. - irinotekano hidrochloridas trihidratas - koncentratas infuziniam tirpalui - 20 mg/ml - irinotecan
irinotecan actavis
actavis group ptc ehf. - irinotekano hidrochloridas trihidratas - koncentratas infuziniam tirpalui - 20 mg/ml - irinotecan
irinotecan fresenius
fresenius kabi polska sp.z.o.o. - irinotekano hidrochloridas trihidratas - koncentratas infuziniam tirpalui - 20 mg/ml - irinotecan
irinotecan kabi
fresenius kabi polska sp.z.o.o. - irinotekano hidrochloridas trihidratas - koncentratas infuziniam tirpalui - 20 mg/ml - irinotecan
irinotecan mylan [irinotecan strides]
mylan s.a.s. - irinotekano hidrochloridas trihidratas - koncentratas infuziniam tirpalui - 20 mg/ml - irinotecan
irinotecan seacross
seacross pharmaceuticals limited - irinotekano hidrochloridas trihidratas - koncentratas infuziniam tirpalui - 20 mg/ml - irinotecan
irinotecan ebewe
ebewe pharma ges.m.b.h. nfg. kg - irinotekanas - koncentratas infuziniam tirpalui - 20 mg/ml - irinotecan
onivyde pegylated liposomal (previously known as onivyde)
les laboratoires servier - irinotecan anhydrous free-base - kasos navikai - antinavikiniai vaistai - suaugusių pacientų, kuriems pasireiškė gemcitabino terapija, metastazavusios kasos adenokarcinomos gydymas kartu su 5 fluorouracilu (5 fu) ir leukovorinu (lv).
lonsurf
les laboratoires servier - trifluridine, tipiracil hidrochloridas - kolorektaliniai navikai - antinavikiniai vaistai - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
skysona
bluebird bio (netherlands) b.v. - elivaldogene autotemcel - adrenoleukodystrophy - kiti nervų sistemos vaistai - treatment of early cerebral adrenoleukodystrophy in patients less than 18 years of age, with an abcd1 genetic mutation, and for whom a human leukocyte antigen (hla) matched sibling haematopoietic stem cell donor is not available.